🧭 
NKE | Seasonal Reversal Cycle Loading…
NKE has historically shown strong Q4–Q1 recoveries following multi-quarter downtrends — a pattern tied to consumer rotation and holiday-season demand.
Current structure shows a breakout from the 2-year falling channel, with the next cyclical wave aiming toward $164 resistance.
🟢 Bullish Case:
Breakout + retest of the 0.786 Fib zone
Seasonality aligns with Nike’s strongest sales quarter (Oct–Feb)
Long accumulation zone between $68–$75 acting as springboard
🔴 Bearish Risk:
Failure to hold above $68–$70 channel midpoint could revisit $56–$60
EPS weakness or margin compression could delay recovery
📅 Historical pattern:
Past 5 years → avg. +14–18% return from Oct–Jan
Trend suggests cyclical rally ahead if retail sentiment holds.
🎯 Targets:
Short-term: $92–$108
Mid-term: $135
Long-term cyclical magnet: $164
#NKE #Seasonality #VolanX #AITrading #WaverVanir
NKE | Seasonal Reversal Cycle Loading…NKE has historically shown strong Q4–Q1 recoveries following multi-quarter downtrends — a pattern tied to consumer rotation and holiday-season demand.Current structure shows a breakout from the 2-year falling channel, with the next cyclical wave aiming toward $164 resistance.
🟢 Bullish Case:
Breakout + retest of the 0.786 Fib zone
Seasonality aligns with Nike’s strongest sales quarter (Oct–Feb)
Long accumulation zone between $68–$75 acting as springboard
🔴 Bearish Risk:
Failure to hold above $68–$70 channel midpoint could revisit $56–$60
EPS weakness or margin compression could delay recovery
📅 Historical pattern:
Past 5 years → avg. +14–18% return from Oct–Jan
Trend suggests cyclical rally ahead if retail sentiment holds.
🎯 Targets:
Short-term: $92–$108
Mid-term: $135
Long-term cyclical magnet: $164
#NKE #Seasonality #VolanX #AITrading #WaverVanir
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.